TABLE 2.

Longitudinal carriage of putative AREF strains in dogs with pyoderma in longitudinal study B

Dog identification no.ST of AREF isolate or resulta for sample from day:
1234681012141618202229
    B1b192+++++++++++
    B2b
    B3b++78++NR
    B4c+78+++++NR++
    B5c192++NR+
    B6cNR-19++++++++++
    B7cNR
    B8cNRNRNRNRNR
    B9d19NR+++++++
    B10d19+NR++NR
    B11dNR78+NRNRNR
    B12dNR78NRNRNR
  • a Samples from 12 dogs (B1 to B12) with pyoderma being treated with β-lactams were analyzed. Numbers refer to STs of isolates verified as AREF. +, putative AREF isolate, not characterized; −, no growth on Slanetz-Bartley agar with ampicillin; NR, sample not received.

  • b Dog was treated daily with amoxicillin-clavulanic acid tablets from day 1 until day 14.

  • c Dog was treated daily with cephalexin tablets from day 1 until day 14.

  • d Dog was treated by cefovecin injection on day 1.